News | Magnetic Resonance Imaging (MRI) | October 27, 2014

Company will also feature DV25.0 Continuum Pak, full Silent Suite at RSNA 2014

 GE Signa PET/MR Improves Image Quality With Time-of-Flight Capability

October 27, 2014 — At this year’s RSNA, GE Healthcare will showcase the Signa PET/MR, a time-of-flight (TOF) capable, integrated, simultaneous positron emission tomography/magnetic resonance (PET/MR) system.

The Signa PET/MR features GE’s new, exclusive MR-compatible silicon photomultiplier detector (SiPM) technology. This new digital detector is characterized by its enhanced sensitivity; it is up to three times more sensitive than GE Healthcare’s Discovery PET/CT 690. It also features fast coincidence timing resolution enabling TOF reconstruction. With TOF reconstruction, the arrival times of each coincident pair of photons are more precisely detected, and the time difference between them is used to localize the PET signal accurately. TOF helps to improve PET image quality with the potential for higher structural detail and signal-to-noise ratio. The Signa PET/MR is designed to be fully upgradable from a Discovery MR750w 3.0T.

New solutions with the DV25.0 Continuum Pak will be introduced for the Discovery line as well as Optima 450w and 450w GEM platforms at this year’s RSNA. The new features focus on the most challenging areas for today’s clinical users, including solutions to address productivity with up to 40 percent reduction of pre-scan time achieved through the new eXpress Prescan 2.0.

The next steps in patient comfort include a full Silent Suite that includes coverage across the body as well as diffusion imaging within 11dB(A). Features of the newly introduced Freedom Body Pak deliver computed tomography (CT)-like speed for body exams with the advantage of MR contrast. Further clinical enhancements include solutions for neurology as well as cardiac applications that help to address challenging patient situations through faster imaging and whole heart acquisitions in a single breath-hold.

The Signa PET/MR is 510(k) pending at the U.S. Food and Drug Administration (FDA) and not available for sale in the United States.

For more information: www.gehealthcare.com


Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | FDA

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
Subscribe Now